News

Leap Program·Structural Improvement R&D·Innovation Premier 1000 consecutively selected… Establishing a ‘virtuous cycle of growth’ system of technology-production-exportSource = Provided by Reanzen Co., Ltd.Reanzen Co., Ltd. (CEO Kwon Soon-ik), a bio-convergence specialized company that is attracting attention in the global anti-aging market with its high-functional filler and skin booster products, is in the process of fully implementing technology-centered global scale-up as it has been selected for key government innovation support projects one after another.Recently, Reanzen has been selected for the Ministry of SMEs and Startups' 'Jump-Up Program', 'SME Technology Innovation Development Project (Structural Improvement R&D)', and the Financial Services Commission's 'Innovation Premier 1000'. The organically linked growth strategy from technology development (R&D) to production and export is attracting attention as it is aligned with the direction of the government program.First, the 'Jump-Up Program' is a government policy that focuses on supporting promising small and medium-sized enterprises to enter new markets for three years, and Reanzen will receive comprehensive support including global network connections, policy vouchers, and dedicated directing. It is evaluated that this has laid a solid foundation for expanding into the global market.In addition, Reanzen was selected for the 'Small and Medium Enterprise Technology Innovation Development Project (Structure Improvement R&D)' sector and secured about 500 million won in government subsidies. Through this project, Reanzen plans to fully pursue the development and commercialization of new products using biocompatible, highly functional materials. In particular, it is focusing on strengthening the competitiveness of high value-added products, for which global demand is rapidly increasing in the anti-aging field.Here, it has established itself as a true technology leader by being included in the 'Innovation Premier 1000' project. This project is a national innovation growth strategy in which 12 ministries, including the Financial Services Commission and the Ministry of Trade, Industry and Energy, jointly select excellent companies by industry and provide customized financial and non-financial support until 2026. Reanzen was selected as a key fostering target company among small and medium-sized enterprises in recognition of its unique technological prowess and global expansion potential.Kwon Soon-ik, CEO of Reanzen, said, “Achieving this triple crown is the result of public recognition of Reannzen’s technological prowess and market expansion potential,” and added, “Based on a virtuous cycle of growth that links technological development, product development, and exports, we will leap forward as a leading K-bio company leading the global anti-aging market.”Meanwhile, Reanzen is continuing to grow in the domestic and international medical beauty markets, focusing on high-functional skin beauty products based on biocompatible biomaterials, and is also accelerating the expansion of exports to Singapore, the Middle East, Europe, and other regions.출처 : 파이낸스투데이(http://www.fntoday.co.kr)

Yeongdeok-gun Honorary Ambassador Jeon Jeong-hee and businesspeople share warm solidarityAuthor Jeon Jeong-hee (right), who is currently serving as an honorary ambassador for Yeongdeok-gun, is taking a commemorative photo while donating money as a representative of businesspeople working with Yeongdeok-gun. Novelist Jeon Jeong-hee and like-minded businesspeople donated a total of 5 million won to help recover from the forest fire in Yeongdeok-gun, Gyeongbuk. This donation was a beautiful example of solidarity for the local community, proposed by author Jeon Jeong-hee, who is currently serving as an honorary ambassador for Yeongdeok-gun, and prepared by CEO Kwon Soon-ik of Lienzen Co., Ltd.The donation ceremony was held recently in a quiet atmosphere at Yeongdeok County Office, and the donation will be used to stabilize the lives of residents affected by the forest fire and to restore the region.Those who participated in the donation are as follows:△(주)리엔젠 CEO Kwon Soon-ik △(주)오미나라 CEO Lee Jong-gi △(주)산우 Law Firm CEO Lim Jeong-hyeok △(주)효산엘플 CEO Jang Yeong-hwan △(주)코비코코리아 연재화 CEO △Novelist Jeon Jeong-hee △(주)인천탁주 CEO So Seong-ju Jeong Gyu-seong /(주)서경한우 Advisor Jo Moo-ryeon, etc.Author Jeon Jeong-hee said, "Yeongdeok is the hometown of my heart, and it is a precious region where nature and history live and breathe." She added, "I would like to express my deep gratitude to the businesspeople who joined us in the hopes that this will provide some comfort and help to the residents who are suffering from the recent wildfires."In particular, the former writer has a special affection for the preservation of Yeongdeok-gun's cultural assets and natural environment and has been carrying out various cultural promotion activities, and has been practicing a win-win model in which the region and businesses can grow together.Yeongdeok County officials said, “We would like to express our sincere gratitude to Honorary Ambassador Jeon Jeong-hee, who always shows sincere interest in the region, and to the businesspeople who willingly participated in sharing,” and added, “We will use this donation carefully so that the affected residents can quickly return to their daily lives.”Meanwhile, this donation is an example of how a warm hand of solidarity connecting regions can have a great impact and bring hope, and is expected to be a great help in the restoration and reconstruction of Yeongdeok.출처 : 파이낸스투데이(http://www.fntoday.co.kr)

Reanzen CEO Kwon Soon-Ik (left) and Kim Ki-Soo, Head of the R&D Center, commemorate the company’s selection for the Ministry of SMEs and Startups’ Jump-Up Program with a photo. / Photo provided by ReanzenBio convergence specialist Reanzen announced on the 28th that it has been officially selected as a final recipient of the “2025 Jump-Up Program” led by the Ministry of SMEs and Startups (MSS). The Jump-Up Program is a newly launched government initiative jointly supported by relevant ministries, aimed at helping SMEs systematically and comprehensively expand into new businesses and markets, ultimately scaling up into mid-sized enterprises. A total of 620 companies applied for this year’s program, and following a two-stage evaluation process over the course of three months, 100 companies were selected to receive support over the next three years.[Photo provided by Reanzen]elected companies will receive up to 750 million KRW (approx. $550,000) in R&D funding over a three-year period, with 250 million KRW granted each year. The program also includes customized consulting services to strengthen capabilities in overseas expansion and investment attraction, as well as networking opportunities with buyers and global investors.Since its founding in 2015, Reanzen has focused on the development of functional medical devices and cosmetics based on biocompatible biomaterials. At AMWC 2025, the world’s largest aesthetic medicine congress held in Monaco this March, Reanzen unveiled its latest innovations: UREVS 4DFill, a CaHA-based filler designed to improve volume and stimulate collagen production; and REVS Pro45 Succinate, a skin booster combining low and high molecular weight hyaluronic acid (HA Complex) with succinate, an active ingredient known for modulating inflammatory cytokines.[Photo provided by Reanzen]With its selection for the Jump-Up Program, Reanzen expects to accelerate technological advancement and expand its global export capacity. The company is also set to complete a new manufacturing facility in Pyeongtaek in the second half of this year, which will increase its production capacity tenfold. The facility is equipped with state-of-the-art systems that meet international GMP (Good Manufacturing Practice) standards.Reanzen CEO Kwon Soon-Ik stated, “We are honored to have our technological prowess and growth potential officially recognized through this selection. As a leading player in the global K-beauty industry, we aim to supply anti-aging solutions worldwide and grow into a company that improves the quality of life through technology-driven R&D and global market strategies.”

Successful Participation in the Global Hub of Aesthetic and Anti-Aging MedicineREVS Pro32 and RMT140HPn Attention from Medical Professionals(문화뉴스 박선혜 기자) Global biotech company REANZEN Co., Ltd. participated in the ‘2025 AMWC Monaco (Aesthetic & Anti-Aging Medicine World Congress),’ held at the Grimaldi Forum in Monaco from March 27 to 29, where it presented its leading filler and skin booster products.AMWC is one of the world's most prestigious conferences in aesthetic and anti-aging medicine, bringing together top experts and companies in the field. This year's event saw participation from over 250 countries, featuring global pharmaceutical, medical device, cosmetics, and health supplement companies.REANZEN(CEO: Soon-ik Kwon) showcased its HA filler lineup, including UREVS Fine, Deep, and Volume, as well as its PLA filler, Replengen Ideology. The company also introduced a high-performance skin booster range, featuring REVS Pro32, REVS RMT140HPn, REVS XoRadiance, REVS Booster Serum, REVS TF Collagen Booster, REVS KeraDense, and REVS Lipo SV.Among these, the ‘REVS Pro32,’ which combines low- and high-molecular-weight hyaluronic acid (HA), and ‘REVS RMT140HPn,’ formulated with high-molecular-weight HA (1.4 million Dalton) and salmon DNA-derived PN (PolyNucleotide), gained significant attention from medical professionals and global buyers for their exceptional skin regeneration and long-lasting effects.A REANZEN spokesperson commented, “Medical professionals who visited our booth responded positively to the composition, tissue integration, and treatment efficacy of our REVS and UREVS products. The exhibition led to numerous business meetings, reinforcing the competitiveness of REANZEN's brand and products in the global market. Moving forward, we will continue to drive innovation and expand global partnerships to lead advancements in the aesthetic and medical industries.”Following its participation in AMWC 2025, REANZEN aims to accelerate the expansion of its global distribution network, particularly across Europe, the Middle East, and Asia.문화뉴스 / 박선혜 기자 news@mhns.co.kr출처 : 문화뉴스(https://www.mhns.co.kr)

Reanzen Co., Ltd. held REVS Celebration 2022 for 3 days from November 14th to 16th for 30 Thai doctors and a Thai company, DermAesthetic (CEO: Ananya Pakapark) who regularly use the anti-aging brand "REVS".This event was prepared to express gratitude to Thai doctors and the company who helped promote REVS Products in Thailand in 2022. Reanzen CEO Sun Ik Kwon said, "I hope you to have time to get to know more deeply about our products and create unforgettable memories."On the 14th, the first day of the event, there was a welcome ceremony including the introduction of Reanzen, the manufacturing process of Reanzen's representative product, REVS HA filler, and its strict quality control process.On the 15th, the doctors visited a plastic surgery clinic in Korea to listen to a lecture on REVS Skin Booster and a live seminar performed by an incumbent plastic surgeon. Afterwards, the QnA session was held to ask about the treatment methods and effects to solve the Thai doctors' curiosity. After completing all the training, plastic surgeon provided certificates to the doctors of 20 hospitals in Thailand.On the last day, they visited a plastic surgery clinic specializing in lifting and took a tour to experience the systematic operation process of the hospital.After all the schedules prepared by Reanzen, a gala dinner show was prepared at the hotel banquet hall. At the dinner, various entertainments such as performances, trophy presentations, and small gifts were provided to Thai doctors and Thai company which gave them satisfactions.Reanzen CEO Sun Ik Kwon said "This event was a meaningful time to form a closer relationship with you" and said "I hope you to take a step ahead with REVS and we will provide you a bigger satisfaction with differentiated products."In addition, Reanzen said that this event provided a great help in identifying needs and maintaining relationship with domestic and foreign doctors and companies that use Reanzen's products.

Reanzen booth located at the Laser 1 C roomOn August 28, 2022, the Korean Academy of Obesity & Aesthetic Treatment (hereinafter referred to as KAOT) held the '2022 Korean Academy of Obesity & Aesthetic Treatment 39th Fall Conference' at the Yangjae aT Center in Seoul.This fall conference of the KAOT in 2022 under the theme of "beyond your imagination" was held to make time for practical help by providing a platform for education for obesity, petit plastic surgery, laser, beauty function, and basic science and hospital families. Reanzen Co., Ltd., which participated in this conference, showed the filler with Reanzen's only independent technology and approved as a domestic filler "REVS HA Filler" and the skin booster with PN and HA at the optimized combination "REVS RMT140HPn" and these items caught the attention of many doctors.Jaeho Cho, Director of The Line Plastic Surgery Clinic, giving a lecture on RMT140HPn in the Laser 2 E roomThe Line Plastic Surgery Director Jae-Ho Cho lectures on the key points to prepare for stem cell extraction and the role of stem cells required for large-capacity fat transplantation at this conference, and mentioned the skin booster RMT140HPn and explained the synergistic effect.He added that RMT140HPn has excellent proliferation rates of fibroblasts and procollagen, so it tends to be maximized in combination with the corresponding skin booster.

The Korean Academy of Obesity and Aesthetic Treatment (also known as KAOT) recently held the '2022 Korean Academy for Obesity and Aesthetic Treatment 38th Spring Conference' at the Yangjae aT Center in Seoul.The 38th conference in 2022 was held under the theme of ‘Synergistic Collaboration to the Next Level’, and a large number of cosmetic procedures were presented from basic to complex treatment methods and new cosmetic medical devices. This symposium was held in 7 lecture rooms with the theme of obesity, laser, petit, basics, and beauty function parts in A~G Room. In addition, the active participation of about 120 companies confirmed the industry's high interest in this conference. Director Jo Jae-ho of The Line Plastic Surgery delivered a lecture on how to maximize patient satisfaction with immediate effects and surgical know-how without surgery as a non-surgical lifting complex procedure. Director Cho said, “Aging is a natural phenomenon and aging such as skin dryness, loss of elasticity, and wrinkles progresses, and bone loss and movement proceed due to gravity. We need to maximize the production of fibroblasts and procollagen to build up the optimal environment for collagen production,” he explained, referring to Skin Booster REVS RMT140HPn. "The proliferation of fibroblasts and maximization of procollagen production are excellent enough to be shown by figures," he said. "Recently, when lifting the skin, we do not proceed with one product or method, but maximize the effect with various combinations." Director Cho also added, "The procedure is performed in the direction of maximizing the effect through complex treatment by using HIFU, high frequency, RMT140HPn, and Stem Cell together."

Reanzen Co., Ltd announced on March 4, 2022 that it has achieved domestic approval for HA fillers under the REVS brand. It is characterized by precisely and evenly processing hyaluronic acid gel particles by applying Reanzen's proprietary MGT (Micro Grinding Technology). Hyaluronic acid filler can be treated stably with a soft injection and precise extrusion force. The HA filler developed by Reanzen was developed such a way that it could be selected from three lines, mid-light, mid, and pro, depending on the skin condition of the person receiving the treatment, such as wrinkles, and pursued differentiation from existing fillers. In the HA filler manufacturing process, the crosslinking process is done using a harmful component called BDDE, but the component is removed after the process is completed. Reanzen's HA filler has been recognized for its high safety by removing various harmful substances including BDDE. According to the company, this is possible because Reanzen's HBCT (Hexagonal Block Cross-linking Technology) technology is applied. The company explains that this is because the structure of the filler enables parallel crosslinking of the main raw material in small block units while maintaining a constant temperature. The unique REVS filler structure contributes to the formation of more HA cross-links and a longer duration by delaying the rate of degradation in the body. As the viscoelasticity is maintained for a long period of time, the volume recovery effect is maximized. The effectiveness of REVS has been confirmed through confirmatory clinical trials. Changes were measured after the procedure was performed at 4-week intervals for a total of 70 subjects. Stable durability for up to one year has been proven, and satisfaction with the procedure has been highly evaluated not only in the middle-aged group but also in the younger age group.Reanzen Co., Ltd CEO Kwon Soon-ik said, “With this approval, it became an opportunity to realize one step towards the anti-aging market, which is the dream of all mankind. We will do our best to research and develop products.”

Kwon Soon-ik, CEO of Reanzen Co., Ltd., a company specializing in bio-convergence technology development and manufacturing, announced that he won the '8th Korea National Brand Award' at the "2021 Hallyu Cultural Contribution Awards" held on the 27th. The 2021 Hallyu Cultural Contribution Award was awarded to executives who contributed to the globalization of Hallyu culture, national development, social contribution, and expertise, and was highly praised for promoting Hallyu culture through K-Beauty. Reanzen Co., Ltd. is also a member of K Club, a project that designates and closely supports small and medium-sized companies with competitive own technologies as the Korea Institute of Science and Technology (KIST) family company. Above all, it is a next-generation biotechnology research company that specializes in improving human health and quality of life by focusing on bio-convergence source technologies such as medicines, medical devices, and cosmetics using bio-materials and bio-compatible materials. As it is a company that has strengths as an anti-aging company, it is introducing filler and mesotherapy brand "REVS" to overseas buyers and actively marketing in Thailand, India and Vietnam.In particular, it has attracted orders for "REVS" products in Thailand and is currently exporting them in partnership with two companies, and plans to supply to hospitals and beauty stores in Vietnam. In addition, Reanzen's technology has been recognized and the recognition has gradually been established, prompting requests and inquiries for filler and skin boosters in South America, including China, Russia, and Southeast Asia.Reanzen Co., Ltd CEO Kwon Soon-ik said, “There was an economic downturn due to the COVID-19, but it seems to be the result of continuous communication with domestic and foreign buyers and efforts to develop technology. Based on the goal of reverse aging, we will continue to work hard to promote k-beauty worldwide.” In addition, Reanzen Co., Ltd. is trying to contribute to the national economy in the era of COVID-19 by utilizing its strength as an anti-aging company, and is known as a  company that usually takes the lead for sharing service and for regional development. It has been selected as a company in the 2019 Korea National Brand Awards.